Forever young: the firms keeping people active

In rude health: AstraZeneca, Britain’s biggest drugmaker, has “risen to the challenge” of US healthcare providers negotiating drug prices by posting “solid first-half sales growth”, says Derren Nathan

HOW AI IS SUPERCHARGING THE SECTOR

CITY

UK equities are having their time in the sun. The FTSE 100 recently hit an all-time high of 9,000, driven by a broad recovery in equity prices. To put it another way, the rally wasn’t just driven by a

Rich pickings: Many in the City of London are fretting about the lack of inward investment, but if there is one financial British product North Americans cannot get enough of it’s pensions, says Liam

Last year, Henderson European Focus Trust and Henderson EuroTrust merged to form Henderson European Trust (LSE: HET), with £680m of assets (after significant cash exits) and a well-regarded management